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To perform a systematic review of the utility of the Beck Depression Inventory for detecting depression in
medical settings, this article focuses on the revised version of the scale (Beck Depression Inventory-II), which was
reformulated according to the DSM-IV criteria for major depression. We examined relevant investigations with
the Beck Depression Inventory-II for measuring depression in medical settings to provide guidelines for
practicing clinicians. Considering the inclusion and exclusion criteria seventy articles were retained. Validation
studies of the Beck Depression Inventory-II, in both primary care and hospital settings, were found for clinics of
cardiology, neurology, obstetrics, brain injury, nephrology, chronic pain, chronic fatigue, oncology, and
infectious disease. The Beck Depression Inventory-II showed high reliability and good correlation with measures
of depression and anxiety. Its threshold for detecting depression varied according to the type of patients,
suggesting the need for adjusted cut-off points. The somatic and cognitive-affective dimension described the
latent structure of the instrument. The Beck Depression Inventory-II can be easily adapted in most clinical
conditions for detecting major depression and recommending an appropriate intervention. Although this scale
represents a sound path for detecting depression in patients with medical conditions, the clinician should seek
evidence for how to interpret the score before using the Beck Depression Inventory-II to make clinical decisions.
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& INTRODUCTION
Patients with chronic medical illness have a high
prevalence of major depressive illness (1). Depressive
symptoms may co-occur with serious medical illnesses,
such as heart disease, stroke, cancer, neurological disease,
HIV infection, and diabetes (1-3). The functional impair-
ment associated with medical illnesses often causes depres-
sion. Patients who present depression along with medical
illness tend to have more severe symptoms, more difficulty
adjusting to their health condition, and more medical costs
than patients who do not have co-existing depression (2).
While prompt treatment of depression can improve the
outcome of the co-occurring physical illness, proper and
early recognition of treatable depression can result in a
faster recovery and can shorten the patient’s hospital stay.
Formal assessment of depression by a liaison psychiatrist
or clinician-administered instruments, such as the Hamilton
Depression Rating Scale (4) and the Montgomery-A˚sberg
Depression Rating Scale (5), are onerous to implement in
routine clinical settings. In contrast, self-report measures for
depression can be cost-effective for use in busy specialty
medical clinics. Throughout the second half of the 20th
century, along with the discovery of effective antidepressant
drugs and the development of cognitive-behavioral therapy,
several patient-rated assessment scales for detecting depres-
sion were proposed. Popular instruments include the Beck
Depression Inventory (BDI) (6), the Self-Rating Depression
Scale (7), the Center for Epidemiologic Studies Depression
Scale (8), the Patient Health Questionnaire-9 (9), the
Inventory of Depressive Symptomatology (10), and the
Depression in the Medically Ill (11). Alternative scales have
been developed to measure depression in specific popula-
tions, such as postpartum women (12) and patients with
schizophrenia (13). Other scales have been devoted to
quantify depression in specific age groups, such as
adolescents (14) and the elderly (15). The utility of these
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scales in the medically ill is challenging because the
frequent presence of somatic symptoms in physical diseases
can mislead their score interpretation. If the clinician is
unable to decide which existing instrument to use and how
to interpret the results, the advancement of self-rating scales
can represent a step backward.
Among the investigations on using self-assessment
measures to evaluate depression, the BDI outnumbers the
other measures in the amount of published research: there
are more than 7,000 studies so far using this scale. Aaron T.
Beck and colleagues developed the 21-item BDI in 1961 to
aid clinicians in the assessment of psychotherapy for
depression (6). The easy applicability and psychometric
soundness of this scale have popularized its use in a variety
of samples (16-19) and in healthcare settings worldwide (20-
22). This inventory has received two major revisions: in 1978
as BDI-IA (23) and in 1996 as BDI-II (24). This later
reformulation covers psychological and somatic manifesta-
tions of a two-week major depressive episode, as operatio-
nalized in the DSM-IV (25). Four items of the BDI-IA (weight
loss, distorted body image, somatic preoccupation, and
inability to work) were replaced with agitation, worthless-
ness, difficulty concentrating, and energy loss to assess the
intensity of depression. The items of appetite and sleep
changes were amended to evaluate the increase and
decrease in depression-related vegetative behaviors (24,26-
28). Different from the original version, which intended to
measure negative cognitions of depression, the BDI-II does
not reflect any particular theory of depression. The English
version of BDI-II has been translated and validated in 17
languages so far, and it is used among countries in Europe,
the Middle East, Asia, and Latin America (29-32).
Investigations on depression and its instrumentation
must be considered in view of the pressure for evidence-
based decisions in clinical practice and the information
explosion of the literature. Recently, the BDI-II has been
ever-increasingly used in the medically ill to evaluate
depressive states that occur at high prevalence in healthcare
settings. The authors systematically reviewed the validity of
the BDI-II to quantify the severity of depression among
medical patients and discuss the interpretation of its metric
conventions. The performance of the BDI-II (and its short
version) among patients with medical illnesses who often
present somatic complaints is contrasted with its perfor-
mance among non-medical patients, among whom psycho-
logical symptoms are the most prominent features.
& METHODS
Both investigators, with previous experience on psycho-
metric instruments, conducted this systematic review by
searching the Web of Sciences (ISI), Medline, and PsycINFO
databases. The following MeSH terms were used to scan
studies through the search builder of each database:
‘‘valid*’’ OR ‘‘reliab*’’ OR ‘‘sensitiv*’’ OR ‘‘specific*’’ OR
‘‘concurrent’’ OR ‘‘divergent’’ OR ‘‘convergent’’ OR ‘‘factor
analysis’’. Following the search, we filtered articles contain-
ing the term ‘‘Beck Depression Inventory’’ published during
the time period ‘‘1/1/1996 to 10/10/2012’’. There was no
language or age range restriction. The initial search resulted
in 822 retrieved articles, with 409 from ISI, 328 from
Medline, and 85 from PsycINFO. The reference sections of
the review articles of the depression instruments (33-35) and
book chapters (36-38) were examined to identify potential
studies. Additional efforts to locate relevant studies by hand
and to contact experts in the field identified seven
psychometric articles on medical samples, totaling 829
articles.
After checking for duplication and overlap, 528 articles
remained in the list. Filtering non-medical articles, we
eliminated 170 articles in which ‘‘student,’’ ‘‘psychiatric,’’ or
‘‘community’’ was mentioned in the title or abstract. The
retained 358 articles were screened for eligibility by reading
the abstract. Two articles were not accessible, even upon
request to the author, resulting in 356 full-text articles that
were assessed for eligibility.
The exclusion criteria were as follows: (1) non-psycho-
metric studies, such as clinical trials, editorials, letters,
reviews, meta-analyses, practice guideline, randomized
controlled trials, and case reports; (2) non-medical samples
(student, psychiatric, or non-clinical); (3) small sample size
(N,30); (4) BDI-I; and (5) reanalysis or duplicated analysis
of an original dataset. The sample was considered ‘‘non-
clinical’’ when study participants consisted of workers,
caregivers, and community dwellers. Regardless of the
nosological controversy of chronic fatigue syndrome and
chronic pain as medical illnesses, these conditions were
included due to their high occurrence in healthcare settings.
Samples with less than 30 participants were only retained
when the study addressed a very important problem, such
as between-version comparison or content analysis. A
summary analysis of the complete sample was preferable
when multiple analyses were available (such as separate
reports by gender, ethnicity, or depressed versus non-
depressed groups).
The reasons for excluding 286 articles were as following:
174 studies did not contain the original data using the BDI-II
(167 non-psychometric studies and seven reviews); 95
studies utilized non-medical samples (34 student samples,
31 psychiatric samples, and 30 non-clinical samples); 13
studies provided a reanalysis or secondary data analysis;
three studies used BDI-I; and one study had a small sample
size. The final list resulted in 70 articles that are dedicated to
investigating the psychometric performance of the BDI-II in
medical patients. The flowchart in Figure 1 displays each
step of the search process.
Studies on medical diseases were grouped according to
the sample recruitment source as outpatients or primary
care (k = 52) and hospital (k = 12) (Table 1). Studies
investigating the short version BDI-FS (k = 10) are displayed
separately. Four studies reported data on both BDI-II and
BDI-FS. Several investigations did not provide a clear
description of the healthcare setting or recruited partici-
pants from different levels of health service. Likewise, the
heterogeneous selection of patients might reflect different
groups of participants or stages of disease course. Sixteen
studies reported a sample size with less than 100 respon-
dents, but all of the studies had more than the minimum of
30 subjects.
Among the 70 retained studies, the BDI-II was adminis-
tered to adults in primary care (k = 4) and clinics of
cardiology (k = 12), neurology (k = 12), obstetrics (k = 8),
brain injury (k = 6), nephrology (k = 5), chronic pain (k = 4),
chronic fatigue (k = 4), oncology (k = 3), and infectious
disease (k = 3). Only two studies assessed adolescent
medical patients (39,40).
Almost all of the identified studies were published after
2000, and the great majority (approximately 64%) of studies
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was published in the past five years, suggesting a recent
trend for using the BDI-II in medical settings. Nearly 70% of
the articles applied the English version of BDI-II, but 13 non-
English versions of the scale were found.
Overview
The BDI-II performed well in adult patients with a wide
array of medical diseases (Table 1). For the purpose of
comparison, data from Beck’s studies on non-medical and
medical samples (24,26) are listed as normative references.
Usually, non-patient samples reported the item scores in
the lower part of the range of possible scores (from 0 to 3),
with a skewed distribution of item scores. Based on scores
of 500 psychiatric outpatients, Beck et al. (24) suggested
the following ranges of BDI-II cut-off scores for depres-
sion: 0–13 (minimal), 14–19 (mild), 20–28 (moderate), and
29–63 (severe). As an example, the mean score of the BDI-
II in samples with mood disorder was M = 26.6, and the
mean scores for major depressive episode, recurrent
depression, and dysthymia were 28.1, 29.4, and 24.0,
respectively.
Confirming the expectation that medical patients would
report more somatic symptoms, most of the investigations
reported a slightly higher mean total score for medical
patients than non-patients (Table 1), but scores were still
around or below the threshold of 13/14 that is recom-
mended by Beck to detect mild depression. Exceptions of
this observation were studies on chronic pain (29,61,70,77),
with mean total scores ranging from 17.2 to 26.9. The type of
respondents might influence item endorsement and the
scale total score.
In comparison with the previous version, the item
characteristics of the BDI-II have been changed in terms of
endorsement rate, homogeneity, and content coverage (34).
The homogeneity of the scale was described for 17 of 21 items
in the original study (24), showing acceptable item-total
Figure 1 - Flowchart of the search to scan for studies investigating psychometric properties of the Beck Depression Inventory-II among
medical patients.
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Table 1 - Description of psychometric studies of the Beck Depression Inventory-II in medical samples by language
version, sample size (N), sample description, gender distribution (%W), mean score (SD), and reliability (Cronbach’s
alpha).
Authors, year Language N Sample description %W Mean Score (SD) Alpha
Normative sample
Beck et al., 1996 (24) English 120 College students 44 12.6 (9.9) 0.93
500 Psychiatric outpatients 62 22.5 (12.8) 0.92
Outpatients/Primary Care (k = 52)
Arnarson et al., 2008 (41) Icelandic 248 Adult outpatients 82 21.3 (12.2) 0.93
Arnau et al., 2001 (42) English 333 Adult - primary care 69 8.7 (9.4) 0.94
Brown et al., 2012 (43) English 111 Chronic fatigue outpatients 83 17.7 (9.1) 0.89
Beck & Gable, 2001 (44) English 150 Postpartum outpatients 100 NR 0.91
Bunevicius et al., 2012 (45) Lithuanian 522 Coronary outpatients 28 11.0 (8.2) 0.85
Carney et al., 2009 (46) English 140 Insomnia outpatients 74 14.1 (10.2) 0.91
Carvalho Bos et al., 2009 (47) Portuguese 331 Pregnancy outpatients 100 NR 0.88
354 Postpartum outpatients 100 NR 0.89
Chaudron et al., 2010 (48) English 198 Postpartum outpatients 100 NR NR
Chilcot et al., 2008 (49) English 40 Renal hemodialysis outpatients 40 11.1-12.9 (9.3-9.4) NR
Chilcot et al., 2011 (50) English 460 Renal disease outpatients 35 11.9 (8.3) NR
Chung et al., 2010 (51) Chinese 62 Heart disease outpatients 31 18.2 (7.9) NR
Corbie`re et al., 2011 (29) French 206 Chronic pain outpatients 53 17.2 (11.5) 0.84
Dbouk et al., 2008 (52) English 129 Hepatitis C outpatients 50 17.1 (11.6) NR
de Souza et al., 2010 (53) English 50 Huntington’s disease 48 8.8 (8.9) ND 26.8 (6.9) D NR
del Pino Pe´rez et al., 2012 (54) Spanish 205 Coronary outpatients 26 9.2 (7.6) NR
Dutton et al., 2004;
Grothe et al., 2005 (55,56)
English 220 Adult - primary care 52 12.6 (10.4) 0.90
Findler et al., 2001 (57) English 98 Traumatic brain injury (mild) 55 12.2 (9.6) NR
228 Traumatic brain injury
(moderate to severe)
33 9.7 (8.1) NR
Frasure-Smith & Lespe´rance, 2008 (58) English/French 804 Coronary outpatients 19 NR 0.90
Griffith et al., 2005 (59) English 132 Epilepsy outpatients 72 15.9 (11.1) NR
Hamid et al., 2004 (60) Arabic 493 Women - primary care 100 13.0 (8.1) NR
Harris & D’Eon, 2008 (61) English 481 Chronic pain outpatients 58 26.9 (11.7) 0.92
Hayden et al., 2012 (62) English 83 Obese bariatric outpatients 71 13.4 (9.1) 0.89
Jones et al., 2005 (63) English 174 Epilepsy outpatients 66 NR 0.94
Kanner et al., 2010 (64) English 193 Epilepsy outpatients 68 10.6 (6.3) NR
King et al., 2012 (65) English 489 Traumatic brain injury 10 19.7 (11.8) NR
Kiropoulos et al., 2012 (66) English 152 Coronary heart disease outpatients 34 9.4 (8.9) ND 17.8 (8.7) D NR
Kirsch-Darrow et al., 2011 (67) English 161 Parkinson outpatients 31 9.5 (7.2) 0.89
Ko et al., 2012 (68) Korean 121 Epilepsy outpatients 35 9.7 (6.3) ND 29.9 (11.7) D NR
Lipps et al., 2010 (69) English 191 HIV infection outpatients 61 14.1 (11.0) W 10.2 (9.1) M 0,89
Lopez et al., 2012 (70) English 345 Chronic pain outpatients 0 23.0 (12.2) 0.93
Masuda et al., 2012 (71) Japanese 327 Myasthenia gravis outpatients 67 11.3 (7.9) NR
Neitzer et al., 2012 (72) English 150 Renal hemodialysis outpatients 48 12.3 (10.8) NR
Ooms et al., 2011 (73) Dutch 136 Tinnitus outpatients 35 11.3 (9.5) NR
Osada et al., 2011 (74) Japanese 56 Fibromyalgia outpatients 86 NR NR
Patterson et al., 2011 (75) English 671 Hepatitis C outpatients 3 16.2 (12.2) 0.84-0.91
Penley et al., 2003 (30) English/Spanish 122 Chronic renal outpatients 41 15.0 (12.5) 0.92
Pereira et al. 2011 (76) Portuguese 503 Pregnant outpatients 100 NR NR
Poole et al., 2009 (77) English 1227 Chronic pain outpatients 62 24.7 (11.6) 0.92
Rampling et al., 2012 (78) English 266 Epilepsy outpatients 59 NR 0.94
Roebuck-Spencer, 2006 (79) English 60 Systemic lupus erythematosus outpatients 80 NR NR
Su et al., 2007 (80) Chinese 185 Pregnant outpatients 100 7.0 (5.0) ND 17.0 (10.2) D NR
Suzuki et al., 2011 (81) Japanese 287 Myasthenia gravis outpatients 67 11.1 (8.1) NR
Tandon et al., 2012 (82) English 95 Perinatal women 100 NR 0.9
Teng et al., 2005 (83) Chinese 203 Postpartum outpatients 100 7.8 (6.3) ND 25.8 (10.4) D NR
Turner et al., 2012 (84) English 72 Stroke outpatients 47 13.4 (12.9) 0.94
Turner-Stokes et al., 2005 (85) English 114 Brain injury outpatients 43 Median 10 (IQR 5-19) NR
Viljoen et al., 2003 (86) English 127 Adult - primary care 63 NR NR
Wan Mahmud et al., 2004 (87) Malay 61 Postpartum I outpatients 100 4.4 (5.5) 0.89
354 Postpartum II outpatients 100 6.2 (6.4)
Warmenhoven et al., 2012 (88) Dutch 46 Cancer outpatients 43 14.7 (9.9) NR
Williams et al., 2012 (89) English 229 Parkinson disease outpatients 33 6.5 (5.2) ND 14.7 (7.4) D 0.90
Young et al., 2007 (90) English 194 Cardiac outpatients 35 8.6-13.4 (7.7-12.3) NR
Zahodne et al., 2009 (91) English 71 Parkinson disease outpatients 32 11.7 (7.9) NR
Hospitalized (k = 12)
Di Benedetto et al., 2006 (92) English 81 Acute cardiac syndrome 19 NR . 0.90
Gorenstein et al., 2011 (93) Portuguese 334 Adult - hospitalized 48 12.2 (11.6) 0.91
170 physically disabled
164 intellectually disabled
14.5 (11.2)
9.7 (11.4)
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correlations of rit$0.5 (108). Different item endorsements and
coverage are reported for different versions of the instru-
ment: substantial item-total correlation was described for 15
items in the Brazilian-Portuguese version (93) and 10 items in
the Arabic version (32). Direct comparison of the scores
between different language versions should be avoided.
In contrast with patient samples, somatic items, such as
‘‘change in sleeping pattern’’ and ‘‘change in appetite,’’
presented low scores for non-clinical samples. However,
‘‘tiredness or fatigue,’’ might present special clinical
significance in patients with chronic fatigue syndrome (43)
or cardiac coronary disease (45,51). Regardless of the
severity of depression, the item ‘‘loss of sexual interest’’
displayed the worst item-total correlation, although it was
significantly related to the whole construct under considera-
tion (23,24). Thombs et al. (101) suggested that the
assessment of symptom severity with BDI–II would be
substantially biased in medically ill patients compared with
non-medically ill patients due to the misattribution of
somatic symptoms from medical conditions to depression.
The authors found that post-acute myocardial infarction
patients did not have higher somatic symptom scores than
psychiatry outpatients who were matched on cognitive/
affective scores. Compared with undergraduate students,
somatic symptom scores in cardiac patients were only
approximately one point higher, indicating that somatic
symptom variance is not necessarily related to depression in
medically ill and non-medically ill respondents.
The item ‘‘suicidal thoughts’’ was the least reported item
among non-medical settings; however, a substantial correla-
tion still demonstrates its contribution to depression (23,24).
Investigations on the ability of separate items, e.g.,
‘‘pessimism’’ and ‘‘loss of energy,’’ to predict disease
outcome or treatment response can help clinicians in the
management of depression. The contribution of self-rated
somatic vs. cognitive symptoms in medical samples should
be clarified by item analysis to identify whether items are
appropriately assigned to a scale.
BDI-Fast Screen
Experts view somatic symptoms among medical patient
as the harbinger of depression and anxiety in the healthcare
setting (3,109-111). Preferably, the assessment of depression
in patients with medical illness should avoid confounding
physical symptoms. The correct identification of comorbid
depressive disorders in medical patients is crucial in
understanding its origin and in controlling the physical
symptom burden.
Two measures were designed with the objective of
eliminating somatic items. The first proposed measure is
the Hospital Anxiety Depression Scale (HADS) (112), which
has a seven-item depression subscale. Despite the lack of
comprehensive data on its psychometric properties (113)
and challenges to its factorial validity (114), the HADS
remained widely used as a research measure of depression
in the medically ill.
Authors, year Language N Sample description %W Mean Score (SD) Alpha
Homaifar et al., 2009 (94) English 52 Traumatic brain injury * 10 25 (14.6) NR
Huffman et al., 2010 (95) English 131 Myocardial infarction 20 9.8 (9.4) NR
Jamroz-Wisniewska et al., 2007 (96) Polish 104 Multiple sclerosis 74 14.4 (9.2) NR
Low & Hubley, 2007 (97) English 119 Coronary disease 25 8.0 (7.1) 0.89
Pietsch et al., 2012 (40) German 314 Adolescents patients*
(252 hospital inpatients)
60 7.5 (6.5) ND 25.8 (10.1) D 0.91
Rowland et al., 2005 (98) English 51 Traumatic brain injury 28 5.6 ND 20.1 D NR
Siegert et al., 2009 (99) English 353 Neurological diseases 40 13.6 (10.1) 0.89
Thomas et al., 2008 (100) English 50 Stroke 38 12.7 (8.9) NR
Thombs et al., 2008 (101) English/French 477 Acute myocardial infarction 17 9.2 (7.9) NR
Tully et al., 2011 (102) English 226 Cardiac heart disease 17 8.6 (6.2) a
9.1 (6.4) b
0.85
0.87
BDI Fast Screen version (k = 10)
Beck et al., 1997 (26) English 50 Medical inpatients 60 5.8 (4.5) 0.86
Brown et al., 2012 (43){ English 111 Chronic fatigue outpatients 83 4.3 (3.2) NR
Neitzer et al., 2012 (72){ English 146 Renal hemodialysis outpatients 48 2.7 (3.4) NR
Pietsch et al., 2012 (40){ German 314 Adolescents*
(252 hospital inpatients)
60 1.9 (2.4) ND 8.1 (3.5) D 0.82
Poole et al., 2009 (103){ English 1227 Chronic pain outpatients 62 7.1 (4.30) 0.84
Scheinthal et al., 2001 (104) English 75 Geriatric outpatients 56 2.3 (3.1) 0.83
Servaes et al., 2000 (105) Dutch 85
16
Disease-free cancer outpatients
Chronic fatigue outpatients
43.5
50
0.4-2.3 (0.9-1.8)
2.6 (1.8)
NR
Servaes et al., 2002 (106) Dutch 57
57
Disease-free breast cancer outpatients
Chronic fatigue outpatients
100
100
2.3-4.2 (2.2-3.9)
3.3 (2.6)
NR
Steer et al., 1999 (107) English 120 Medical outpatients 50 2.2 (3.0) 0.85
Winter et al., 1999 (39) English 100 Adolescent outpatients 50 1.9 (3.1) 0.88
N: sample size;%W: percentage of women; SD: standard deviation; Alpha: Cronbach’s alpha coefficient of internal consistency;
NR: not reported.
M: men, W: women; ND: non-depressed; D: depressed; a: pre-surgery; b: post-surgery.
*Mixed sample of in- and outpatients.
{Separate analysis of the short version of the BDI-II in the same study.
IQR: interquartile range.
Table 1 - Continued.
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The seven-item BDI for Primary Care (BDI-PC) (26) was
developed in 1997 after removing somatic items, such as
fatigue and sleep problems, from the BDI. This version was
projected for evaluating depression in patients whose
behavioral and somatic symptoms are attributable to
biological, medical, alcohol, and/or substance abuse pro-
blems that may confound the diagnosis of depression. The
BDI-PC was later renamed the BDI H Fast Screen for Medical
Patients (BDI-FS), and it consists of items 1 to 4 and 7 to 9 of
the BDI-II (27).
The BDI-FS requires less than five minutes for comple-
tion, and scoring is similar to the BDI-II. For interpretation,
the manual suggests that scores 0–3 indicate minimal
depression; 4–6 indicate mild depression; 7–9 indicate
moderate depression; and 10–21 indicate severe depression
(27). Validation studies (k = 10) have demonstrated the
ability of this non-somatic scale to discriminate depressed
vs. non-depressed medical patients (39,26,104,107), chronic
pain patients (103), and conditions where fatigue is a
prominent feature (43,105,106). Less popular than its full
version, more investigations are needed to establish the
utility of this short version in medical settings before
recommending its extensive use.
Reliability
Thirty-seven of 70 retrieved psychometric articles (52.9%)
did not report reliability coefficients for the data. In
comparison to the internal consistency of previous versions
of the BDI (average Cronbach’s alpha coefficient of approxi-
mately 0.85) (23), the reliability of the BDI-II among medical
samples was satisfactory, with an alpha of approximately 0.9,
ranging between 0.84 and 0.94 (Table 1). In addition, Beck (26)
reported a coefficient of 0.86 for the BDI-FS, and further
studies reported the coefficient ranging from 0.82-0.88 (39,40).
No information on the retest reliability is available for
medical samples. However, the stability of the BDI-II, as
expressed by retest coefficients of Pearson’s r of 0.92 and 0.93,
was reported by Beck and colleagues (24) for psychiatric and
student samples, respectively. Further evidence of acceptable
stability through re-application of the BDI-II was demon-
strated for student samples (range: 0.73-0.96) (115,116).
The retest effect – that is, lower scores on the second
application, even without intervention – may affect the
reliability of BDI-II in healthcare settings. This effect could
be unrelated to a true change in severity and could be
purely the result of the measurement process. Although this
fact would not preclude using this scale in follow-up or
interventional studies among medical patients, nothing
should be stated concerning the scale performance in this
respect. Therefore, clinicians should be careful when
making important treatment decisions based on non-
empirical information assumed from non-clinical samples.
Item Response Theory
Most validation studies of BDI-II were analyzed in
accordance with classic test theory, assuming a true score
for each respondent’s summed score and disregarding the
measurement error. In other words, two individuals with
the same total score may differ greatly in terms of relative
severity and frequency of symptoms. This discrepancy
might be particularly taxing in medical settings, where
physical symptoms are common complaints and overlap
with ‘‘true’’ depression-related somatic symptoms.
In the last decades, the item response theory (IRT) is an
increasingly used method in psychometrics, in addition to
the dominant classic test theory of true score paradigm.
Briefly, the IRT distinguishes between moderate and severe
cases of depression using item-level analysis to account for
measurement error (117). The response of a respondent for a
given ability should be modeled to each item in the test. For
example, when a given depression scale is composed only of
items that measure mild depression, this instrument would
have great difficulty identifying severe depression because
both levels of severity should be characterized by high
scores on all items. In addition, if items assessing psycho-
logical and physical symptoms were only loosely related, a
single score would not distinguish between two potentially
different groups of depressed patients - with primarily
psychological or with primarily vegetative symptoms. This
scenario is particularly pressing in medical settings that are
investigating clinical changes in depressive syndrome.
Seigert and colleagues (99) reported an illuminating study
after examining each BDI-II item for differential item
functioning in a neurological sample (n = 315). The authors
identified misfits to model expectations for three items that
seemed to measure different dimensions: changes in sleeping
pattern, changes in appetite, and loss of interest in sex. These
vegetative items were removed and re-scored in an iterative
fashion to the scale. In the real world, the likelihood of
receiving a rating of 1 on the insomnia item was essentially
the same, regardless of the overall severity of depression, but
the likelihood of receiving a rating of 3 on sad mood could be
low, even when overall depression was severe.
Waller and colleagues (118) investigated the latent
structure of the BDI-II through differential item functioning
and item level factor analysis in samples of women with
breast cancer and women with clinical depression. Items of
negative cognitions about the self, e.g., worthlessness, self-
dislike, and punishment feelings, were less likely to be
reported by breast cancer patients than depressed patients.
Negative cognitions about the self appear to be related to
different factors in breast cancer. The analyses also found
many differences at both the item and factor scale levels,
suggesting caution when interpreting the BDI-II in breast
cancer patients.
These studies advocate that the rating scheme is not ideal
for many BDI-II items, thus affecting the scale’s capacity to
detect change in medical conditions. Systematic IRT analysis
of the BDI-II items can strengthen the scale coverage in
assessing heterogeneous depressive conditions among
medical patients.
Convergent and Divergent Validity
Table 2 displays the studies that compared the BDI-II with
scales measuring depression, anxiety, and miscellaneous
constructs as criteria that were determined at essentially the
same time to check for concurrent validity. The convergent
validity between the BDI-II and the BDI-I was 0.93 (28). The
shorter version, BDI-FS, also presented an acceptable
correlation of 0.85 (72). In general, the overlap of the
construct measured by BDI-II with other widely used scales
to assess depression, e.g., the Center for Epidemiologic
Studies of Depression, the Hamilton Depression Rating
Scale, Edinburg Postnatal Depression Scale, and the
Hospital Anxiety and Depression Scale-Depression, was
adequate and ranged from 0.62 to 0.81 (Table 2).
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Additionally, the convergent validity between the BDI-II
and scales that assess anxiety was significant and differed
across comparison instruments: Beck Anxiety Inventory
(0.60) (24,41), Hamilton’s Anxiety Rating Scale (0.47) (24),
State-Trait Anxiety Inventory (0.83) (92), Penn State Worry
Questionnaire (0.61) (41), and Hospital Anxiety and
Depression Scale-Anxiety (0.65) (41). These results were
expected due to the extent that anxiety symptoms were
highly comorbid with depressive symptoms or that they
could be attributed to the characteristics of the compared
instruments. As a broad indicator of mental health, a high
score on the BDI scale could also be explained by other
disorders, physical illnesses, or social problems (69). Most
likely, the construct covered by the BDI-II is beyond the
‘‘pure’’ depressive-type of psychopathology. As such, the
convergent validity of the scale with hopelessness (24) and
fatigue (105) was also substantial. In the medical setting,
the clinician should not assume depression as a primary
issue when BDI-II is used without a thorough clinical
assessment.
Concerning divergent validity, studies have indicated
poor correlation (r,0.4) with instruments assessing chronic
pain (61), physical health (43), and substance use disorders
(119). Suicidal ideation, which is one of core features of
depression and an item on the BDI-II, was only poorly
correlated with the instrument (24).
Criterion-oriented Validity
Psychometric experts view the interpretation of the raw
scores on tests, such as the BDI-II, as problematic, unless
they are converted into standardized scores (e.g., T score or
stanine method) (108,120). No known standardized norms
have been reported for the BDI-II to date. As an alternative
to the norm-referenced method, the criterion-referenced
method is the most widespread practice for interpreting
BDI-II scores. Usually, the total score is compared with a
cut-off score established according to a gold-standard
criterion (e.g., clinical assessment or structured interview).
When clinicians intend to screen probable cases of major
depression in medical settings, the sensitivity should be
Table 2 - Concurrent validity of the Beck Depression Inventory-II with measures of depression, anxiety, and other
miscellaneous constructs in medical samples.*
Concurrent instrument r Study
Depression measure
BDI-I Beck Depression Inventory – I 0.93 28
BDI-FS Beck Depression Inventory – Fast Screen 0.85 72
HADS-D Hospital Anxiety and Depression Scale-Depression 0.62 - 0.71 26{, 41
CES-D Centre for Epidemiologic Studies of Depression 0.72 - 0.87 29, 41, 52, 63, 69
HRSD Hamilton Rating Scale for Depression - revised 0.71 - 0.75 24, 87
EPDS Edinburgh Postnatal Depression Scale 0.72 - 0.82 44, 83, 87
GDS Geriatric Depression Scale 0.81 104 {
PHQ PRIME-MD Patient Health Questionnaire 0.84 52
CDS Cardiac Depression Scale 0.65; 0.69 66, 92
POMS-D Profile of Mood States Depression Scale 0.77 59
PDSS Postpartum Depression Screening Scale 0.68; 0.81 44, 76
DISC Depression Intensity Scale Circles 0.66 85
NGRS Numbered Graphic Rating Scale 0.65 85
Anxiety measure
BAI Beck Anxiety Inventory 0.60 24, 41
HARS Hamilton Anxiety Rating Scale - revised 0.47 24
STAI State-Trait Anxiety Inventory 0.64; 0.83 66, 92
PSWQ Penn State Worry Questionnaire 0.61 41
HADS-A Hospital Anxiety and Depression Scale-Anxiety 0.65 41
Miscellaneous
SSI Scale for Suicide Ideation 0.37 24
BHS Beck Hopelessness Scale 0.68 24
MPQ-PRI McGill Pain Questionnaire (Pain Rating Index) 0.32 61
SF-36 MH Short Form 36-Item Health Survey – Mental Health 0.45 - 0.70 43{, 57
SF-36 PH Short Form 36-Item Health Survey – Physical Health 0.12 - 0.29 43{, 57
SPS Social Provisions Scale 0.39 - 0.42 69
CIS-F Checklist Individual Strength - Fatigue 0.58 105
NDDI-E Neurologic Disorders Depressive Inventory in Epilepsy 0.81 - 0.85 64, 68
NSI Neurobehavioral Symptom Inventory 0.77 65
MG-QOL Myasthenia Gravis Quality of Life Scale 0.52 71
JFIQ Fibromyalgia Impact Questionnaire 0.58 74
ANAM Automated Neuropsychological Assessment Metrics-Mood 0.67 79
SCQR Stroke Cognitions Questionnaire Revised 0.54 - 0.80 100
STOP-D Screening Tool for Psychological Distress 0.83 90
LARS Lille Apathy Rating Scale 0.45 91
AS Apathy Scale 0.58 91
UPDRS-III Unified Parkinson’s Disease Rating Scale 0.38 91
r: Pearson’s product moment correlation. Negative correlation is omitted in the numerical value.
{The concurrent validity refers to the BDI-FS version.
*A complete list of retrieved studies can be obtained from the authors upon request.
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viewed as the most important indicator to minimize the
chance of false-negative cases (Table 3). Sometimes, the BDI-
II can overestimate the prevalence of depression in
particular conditions, e.g., medically ill patients would
record more items that address physical complaints.
According to the samples, medical studies have reported
good performance with high sensitivity (from 72% to 100%).
Occasionally, the researcher might want to improve the
specificity to select a pure sample of depressed patients. For
research purposes, Beck et al. (24) recommended raising the
cut-off score to 17 to obtain homogeneous samples of
depressed individuals.
According to Table 3, the best cut-off to indicate cases of
depressive syndrome in medical samples was established
on the ground of the unique characteristics of the sample.
The possible threshold ranged widely, from 7 to 22 (89,103).
For example, Poole et al. (103) found that raising the BDI-II
cut-off score to 22 could reduce the number of false-
positives produced by the uneven item response of chronic
pain patients. Consequently, the researcher can change the
flexibility of the cut-off score by comparing different
thresholds for a new sample or study purpose.
A significant diagnostic accuracy of 82% and higher, as
expressed by the area under the receiver operating
characteristics (ROC) curve, was calculated according to
the tradeoff between sensitivity and specificity. However,
the ability of a scale to differentiate between depressive vs.
non-depressive groups depends not only on the sensitivity
and specificity of its cut-off scores but also on the frequency
of the disorder in the samples that are being studied. In
addition, sources of threshold variation may depend on the
type of the sample (outpatient or hospitalized), medical
Table 3 - Criterion validity and cut-off point of the Beck Depression Inventory-II for detecting major depressive episode
in medical samples.
Authors Sample Cut-off Sensitivity Specificity PPV NPV AUC % MDD Criterion
Outpatients
Arnarson et al. (41) Adult outpatients 20 82 75 NR NR 87 42.1 MINI
Arnau et al. (42) Adult - primary care 18 94 92 54 99 96 23.2 PHQ
Beck & Gable 2001 (44) Postpartum outpatients 20 56 100 100 93 95 12 SCID-I
Bunevicius et al. (45) Coronary outpatients 14 89 74 29 98 90 11 MINI
Carney et al. (46) Insomnia outpatients 17 81 79 NR NR 83.8 NR SCID-I
Chaudron et al. (48) Postpartum outpatients 20 45.3 91.1 NR NR 90 37 SCID-I
Chilcot et al. (49) Renal hemodialysis 16 89 87 89 87 96 22.5 MINI
de Souza et al. (53) Huntington’s disease 11 100 66 48 100 85 50 SCAN
Dutton et al. (55) Adult - primary care 14 87.7 83.9 69.5 94.2 91 29.5 PRIME-MD
Frasure-Smith & Lespe´rance (58) Coronary outpatients 14 91.2 77.5 NR NR 92 13.7 SCID-I
Jones et al. (63) Epilepsy outpatients 11 96 80 48 99 94 17.2 MINI
15 84 87 55 97 92 SCID-I
11 95.7 78.3 42 99 94 MINI + SCID
Hayden et al. (62) Obese bariatric
outpatients
13 100 63.9 29.7 100 84.7 13.3 SCID-I
Pereira et al. (76) Pregnant outpatients 16 83.3 93.1 14.3 99.7 95 1.3 DIGS
Rampling et al. (78) Epilepsy outpatients 14 93.6 74 44 98 90 17.7 MDI (ICD-10)
15 93.8 78.9 49.5 98 93 18 MDI (DSM-IV)
Su et al. (80) Pregnant outpatients 12 72.7-75.0 82.7-82.9 NR NR 81.9-86.6 12.4 MINI
Tandon et al. (82) Perinatal women 12 84.4 81.0 NR NR 91 33.7 SCID-I
Teng et al. (83) Postpartum outpatients 14 92 83 42 99 NR 11.8 MINI
12 96 79
Turner et al. (84) Stroke outpatients 11 92 71 NR NR 89 18 SCID-I
Turner-Stokes et al. (85) Brain injury outpatients 14 74 80 69 84 NR 39.8 DSM-IV
Wan Mahmud et al. (87) Postpartum outpatients 9 100 98 87.5 100 99.5 48 CIS
Warmenhoven et al. (88) Cancer outpatients 16 90 69 NR NR 82 22 PRIME-MD
Williams et al. (89) Parkinson outpatients 7 95 60 62 94 85 34.1 SCID-I
Hospital sample
Homaifar et al. (94) Traumatic brain injury 19 87 79 NR NR NR 44.2 SCID-I
Huffman et al. (95) Myocardial infarction 16 88.2 92.1 62.5 98.1 96 13 SCID-I
Low & Hubley (97) Coronary disease 10 100 75 21 100 92 11.8 SCID-I
Pietsch et al. (40) Adolescents 19 86 93 47 99 93 6.7 Kinder-DIPS
BDI-FS
Beck et al. (26) Medical inpatients 4 82 82 NR NR 92 66 PRIME-MD
Neitzer et al. (72) Renal hemodialysis 4 97.2 91.8 81.4 98.9 98 28.7 BDI-II $ 16
Pietsch et al. (40) Adolescents 6 81 90 37 99 92 6.7 Kinder-DIPS
Poole et al. (103) Chronic pain outpatients 4 81 92 NR NR 94 59.4 BDI-II $ 19
5 75 93 NR NR 94 47.8 BDI-II $ 22
Scheinthal et al. (104) Geriatric outpatients 4 100 84 NR NR 93 11 Clinical assessment
Steer et al. (107) Medical outpatients 4 97 99 NR NR 99 24.2 PRIME-MD
Winters et al. (39) Adolescent outpatients 4 91 91 NR NR 98 11 PRIME-MD
PPV: positive predictive value; NPV: negative predictive value; AUC: area under the curve;%MDD: proportion of major depression disorder; NR: not
reported.
PHQ: PRIME-MD Patient Health Questionnaire; MINI: Mini International Neuropsychiatric Interview; PRIME-MD: Primary Care Evaluation of Mental
Disorders; CIS: Clinical Interview Schedule; SCID-I: Structured Clinical Interview for DSM-IV Axis I Diagnosis; MDI: Major Depression Inventory; Kinder-DIPS:
Diagnostisches Interview bei psychischen Sto¨rungen im Kindes und Jugendalter; DIGS: Diagnostic Interview for Genetic Studies; SCAN: Schedules for
Clinical Assessment in Neuropsychiatry.
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disease, and external gold-standard criterion for depression.
Most investigators were unanimous in recommending the
BDI-II as a screening tool in the first phase of two-stage
studies to prevent excessive cases of false positives if the
scale is used as a single tool (121). Caution is warranted
when using the cut-off guidelines presented for criterion-
referenced interpretation and when the BDI-II is misused as
a diagnostic instrument.
The BDI-FS was projected to reduce the number of false-
positives for depression in patients with medical problems.
Similar to its full version, the BDI-FS has shown excellent
performance to detect probable cases of depression with a
cut-off of 4, as expressed by a large area under the ROC
curve (Table 3). To reduce the number of false-positives in
chronic pain patients, Poole et al. (103) suggested raising the
cut-off value to 5. To detect depression in German
adolescent medical patients, Pietsch et al. (40) recom-
mended a threshold of 6. In comparison to the 21-item
version, this non-somatic version of BDI has been less
extensively investigated, which prevents a more conclusive
recommendation for systematic use in medical conditions.
Using rating scales to identify patients for detailed
assessment has been advocated to improve the search for
depression through screening programs, but the detection
rates, treatments, and outcomes are controversial. There is
no agreement on the score interpretation of rating scales as
screening tools, e.g., the Hamilton Rating Scale for
Depression is viewed as a non-trustworthy judgment of
the severity of a patient’s depression (122,123). In addition,
the four-option formulation of the BDI items is viewed as
being more complicated than the yes-no alternative of a
screening questionnaire, such as the Geriatric Depression
Scale (15). Although existing literature supports the use of
the BDI-II as a screening measure of depression, in-depth
analysis of moderator factors that influence the performance
of this scale should be conducted.
Content and Construct Validity
The acceptance of the content as a qualitative representa-
tion of the measured trait is critical for the content validity
of a given scale (124). The BDI-I reflected six of the nine
criteria for DSM-based depression (21,125), while the BDI-II
encompassed all DSM-based depressive symptoms. As a
consequence, the tests’ ability to detect a broader concept of
depression has been changed (28,126). The content covered
by the BDI-II seems adequate but narrower than its former
version (34).
Construct validation interprets a test measure through
a specific attribute or quality that is not ‘‘operationally
defined,’’ demonstrated as a latent structure or construct
(127). Exploratory and confirmatory factor analyses deter-
mine which psychological events make up a test construct
by reducing the item number to explain the structure of data
covariance. This family of multivariate techniques demon-
strates the dimensionality of a given scale and the pattern of
item clustering on one, or more than one, factor (128). A
robust measurement instrument for depression should
establish the dimensions being measured and the types,
categories, and behaviors that constitute an adequate
representation of depression.
Table 4 lists 20 investigations that reported the factor
structure of the BDI-II, which was used in 43% of the
retained studies. These articles were grouped according to
the healthcare setting and the factor extraction framework.
Researchers have adopted both exploratory and confirma-
tory strategies with different purposes, e.g., to identify
problems with items that have non-significant factor
loadings or data cross-validation. The use of the state-of-
art confirmatory approach is a trend in studies investigating
the latent structure of BDI-II.
Using an exploratory strategy, Beck and colleagues
reported a two-factor oblique structure for student and
psychiatric samples (24), the cognitive-affective and
somatic-vegetative dimensions. Although this bidimen-
sional structure could be replicated among medical patients
(30,42,43,50,54,56,75,77,86), several investigators reported
different solutions (29,47,61,67,69,70,87). Somatic symptoms
of depression have clustered as a dominant dimension, e.g.,
in primary care (42,86) and in coronary patients (54), or as
an independent third dimension (29,61,67,69).
These alternative solutions could not be replicated by
confirmatory strategy, but the somatic factor was observed
as an ever-present factor among medical patients (Table 4).
Summarizing the factor structure of the existing BDI
investigations through meta-analysis (35), much of the data
variability can be explained by the common dimension of
"severity of depression" and by the other part, ‘‘somatic
symptoms.’’ Due to the misattribution of somatic symptoms
from medical conditions to depression, the assessment of
depressive symptom severity with the BDI-II can be
substantially biased in medically ill patients compared with
non-medically ill patients. Among factor analytical investi-
gations, the somatic dimension has emerged as being highly
correlated with the cognitive dimension (.0.50, range 0.49-
0.87).
The heterogeneous characteristics of depressive condi-
tions could partially explain these proposed factor struc-
tures in medical patients. The alternative structural analysis
of the BDI-II was strengthened by two model break-
throughs: the hierarchical model and the bifactor model.
The hierarchical structure of higher-order depression to
explain the variance of the lower-order cognitive and
somatic dimensions was tested in several medical samples
(42,54,56,61). Although scant, the bifactor model identified a
scale solution with a general depression, in addition to the
traditional bidimensional structure (50,101). The data
variance of the BDI-II supported a higher order, or a
parallel construct, of ‘‘general depression’’ and suggested
caution when interpreting subscale scores.
& DISCUSSION
The present systematic review is intended to aid practi-
cing professionals and clinical researchers in several
specialties in assessing depression in their patients and in
interpreting the score through the BDI-II. Ideally, deciding
which depression scale is optimal for use in medical settings
should meet some desirable features from the patient’s and
the clinician’s perspectives. Patients should find the
measure user-friendly and the instructions easy to follow.
The questions should be understandable and applicable to
the patient’s problem. The scale should be brief to allow
routine administration at intake and follow-up visits. From
the clinician’s perspective, the instrument should provide
clinically convenient information to increase the efficiency
of medical evaluation. Clinicians should find the instrument
user-friendly and easy to administer and score with
minimal training. To be trustworthy, the information
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provided by any measure for depression should rely on
sound psychometric characteristics and demonstrate good
reliability, validity, and sensitivity to change.
The BDI-II is a brief scale that is acceptable to patients and
clinicians, covers all DSM-IV diagnostic criteria for major
depressive disorder, and stands as a reliable indicator of
symptom severity and suicidal thoughts. Its validity and
case-finding capability as a screening instrument is well
established. Conversely, its use as an indicator of sensitivity
to change, medical patient’s remission status, psychosocial
functioning, and quality of life deserve further investigation.
The BDI-II is copyrighted and must be purchased from the
publisher, which obstructs its wider use. Because direct
comparisons demonstrating that the BDI-II is more reliable
or valid than other depression scales are lacking, it is unwise
to justify the cost of its systematic adoption.
Systematic reviews are susceptible to publication bias, that
is the likelihood of over-representation of positive studies in
contrast with non-significant results that frequently remain
unpublished. In psychometric analyses due to its descriptive
nature this kind of bias is minimized. Despite its reasonable
psychometric characteristics, the BDI-II has some limitations.
The spectrum bias refers to the differential performance of a
test between different settings, thus affecting the general-
izability of the results. For example, the somatic factor is a
primary dimension among medical patients (42,54,86)
instead of depressive cognition in non-clinical individuals.
In addition, the work-up or verification bias occurs when
respondents with positive (or negative) diagnostic procedure
results are preferentially referred to receive verification by
the gold-standard procedure, allowing considerable distor-
tion in the accuracy of a given test. For example, medical
patients with multiple somatic complaints might be routinely
referred to psychiatric assessment and, thus, would be more
likely labeled as depressed. To the extent that these types of
bias may occur, the cut-off scores need to be checked
psychometrically to convey the sample characteristics.
Techniques assessing the item-level (e.g., item-total correla-
tion and IRT analysis) and the scale-level (e.g., signal
detection analysis and factor analysis) can improve the
feasibility and strengthen the validity of using this scale to
detect depressive symptoms in medical settings.
In the healthcare context, the perceived burden of scale
completion by the clinician is the major obstacle to using
standardized scales, such as the Hamilton Depression
Rating Scale, which is unlikely to meet with success. As a
self-report questionnaire to measure depression, the BDI-II
holds the advantages of releasing the overburdened
Table 4 - Construct validity of the latent structure of the Beck Depression Inventory-II in medical samples.
Study Sample Method Factor 1 Factor 2 Factor 3 Factor 4
Normative study
Beck et al. (24) College students EFA Cognitive-affective Somatic-vegetative
Psychiatric outpatients EFA Cognitive-affective Somatic-vegetative
Outpatient/Primary Care
Arnau et al. (42) Adult - primary care PCA Somatic-affective Cognitive (Depression)
Brown et al. (43) Chronic fatigue
outpatients
EFA Cognitive Somatic-affective
Carvalho Bos et al. (47) Pregnancy outpatients PCA Cognitive-affective Anxiety Fatigue
Postpartum outpatients PCA Cognitive-affective Somatic-anxiety Guilt
Chilcot et al. (50) Renal disease outpatients EFA Cognitive Somatic
CFA Cognitive Somatic General depression (G)
Corbie`re et al. (29) Chronic pain outpatients CFA Cognitive Affective Somatic
del Pino Pe´rez et al. (54) Coronary outpatients EFA Somatic-affective Cognitive
CFA Somatic-affective Cognitive (Depression)
Grothe et al. (56) Adult - primary care CFA Cognitive Somatic (Depression)
Harris & D’Eon (61) Chronic pain outpatients CFA Negative attitude Performance difficulty Somatic (Depression)
Kirsch-Darrow et al. (67) Parkinson outpatients CFA Dysphoric mood Loss of interest/pleasure Somatic
Lipps et al. (69) HIV infection outpatients C-PCA Cognitive Affective Somatic
Lopez et al. (70) Chronic pain outpatients EFA Negative rumination Somatic Complaint Mood
Patterson et al. (75) Hepatitis C outpatients EFA Cognitive-affective Somatic
CFA Cognitive-affective Somatic
Penley et al. (30) Chronic renal outpatients CFA Cognitive Somatic-affective
Poole et al. (77)* Chronic pain outpatients EFA Negative thoughts Behavior and activities
CFA Negative thoughts Behavior and activities
Viljoen et al. (86) Adult - primary care EFA Somatic-affective Cognitive (Depression)
Wan Mahmud et al. (87) Postpartum outpatients PCA Affective Somatic Cognitive
Hospital sample
Gorestein et al. (93) Adult - hospitalized EFA Cognitive-affective Somatic
Rowland et al. (98) Traumatic brain injury PCA Negative self-
evaluation
Symptoms of depression Vegetative symptoms
Siegert et al. (99) Neurological disease PCA Cognitive-affective Somatic
CFA Cognitive-affective Somatic
Thombs et al. (101) Acute myocardial infarction CFA Cognitive Somatic General depression (G)
Tully et al. (102) Cardiac heart disease CFA Cognitive Affective Somatic
EFA: exploratory factor analysis; PCA: principal component analysis;
C-PCA: confirmatory principal component analysis; CFA: confirmatory factor analysis.
(G) General factor of depression for the bifactor model.
(Depression) Higher order depression dimension for the hierarchical model.
*Only 18 items were used in the factorial model.
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clinician from the paperwork of scale administration and of
improving the efficiency of the clinical encounter by
providing mental status assessment that correlates well
with clinician-rated tools.
The stated purpose of the BDI-II is not to diagnose major
depressive episode; thus, the investigators must grasp its
appropriateness for detecting depressive symptoms and
monitoring treatment efficacy and its comparability with
observer-rated scales, such as the Hamilton Depression
Rating Scale of Depression or the Montgomery-A˚sberg
Depression Rating Scale. Short scales that are less reliant on
physical symptoms, such as the BDI-FS, should receive
more investigation to demonstrate their usefulness in
screening for depression in medically ill patients.
Finally, the BDI-II suffers from the intrinsic limitations of
self-report questionnaires. Some individuals cannot com-
plete the scale due to illiteracy, physical debility, or
compromised cognitive functioning. The widespread use
of the BDI-II among the elderly is not suggested. Reporting
bias that minimizes or over-reports symptom severity is a
possible hazard that reduces its validity in several patients.
As a tradeoff between the psychometric robustness and
enumerated disadvantages of the BDI-II, this self-report
scale can be viewed as a cost-effective option because it is
inexpensive in terms of professional time needed for
administration and because it correlates well with clinician’s
ratings. Therefore, the BDI-II stands as a valid DSM-based
tool with broad applicability in routine screening for
depression in specialized medical clinics.
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